 |
80 Diseases |  |
11 Trials |
|
11 Trials |  |
865 News |  |
| «12345678910111213 |
- zonisamide / Generic mfg., levetiracetam / Generic mfg., topiramate / Generic mfg.
Enrollment closed: Interdisciplinary Study of Two Novel Anticonvulsants in Alcoholism (clinicaltrials.gov) - Nov 13, 2013
P2, N=160, Active, not recruiting, Sponsor: Boston Medical Center
Recruiting --> Active, not recruiting
- zonisamide / Generic mfg., sodium valproate / Generic mfg.
Trial completion: Comparing The Effect On Cognition Of Adjunctive Therapy With Zonisamide Versus Sodium Valproate (clinicaltrials.gov) - Oct 29, 2013
P4, N=2, Completed, Sponsor: Eisai Limited
Recruiting --> Active, not recruiting Terminated --> Completed
- zonisamide / Generic mfg.
New P2 trial: Zonisamide in Addition to E-CPT-C for Veterans With PTSD and Comorbid Alcohol Dependence (clinicaltrials.gov) - May 3, 2013
P2, N=30, Recruiting, Sponsor: Yale University
- zonisamide / Generic mfg.
New P3 trial: EpsilonZ (clinicaltrials.gov) - Mar 5, 2013
P3, N=32, Recruiting, Sponsor: Assistance Publique - H
- ||||| zonisamide / Generic mfg.
Enrollment change, Monotherapy: Assessing The Long-Term Safety And To Explore The Long-Term Efficacy Of Zonisamide As Monotherapy In Newly Diagnosed Partial Seizures (clinicaltrials.gov) - Jan 9, 2013
P3, N=295, Completed, Sponsor: Eisai Inc.
Terminated --> Completed N=580 --> 295
- || zonisamide / Generic mfg.
New P2/3 trial: ZONIST: Study of Zonisamide in Early Parkinson Disease (clinicaltrials.gov) - Jan 9, 2013
P2/3, N=60, Not yet recruiting, Sponsor: Mazandaran University of Medical Sciences
- ||||||| zonisamide / Generic mfg.
Trial completion, Monotherapy: Assessing The Long-Term Safety And To Explore The Long-Term Efficacy Of Zonisamide As Monotherapy In Newly Diagnosed Partial Seizures (clinicaltrials.gov) - Jan 9, 2013
P3, N=295, Completed, Sponsor: Eisai Inc.
N=580 --> 295 Active, not recruiting --> Completed
- | zonisamide / Generic mfg.
New P2 trial: Zonisamide for the Treatment of Obstructive Sleep Apnea in Overweight/Obese Patients (clinicaltrials.gov) - Jan 8, 2013
P2, N=50, Completed, Sponsor: G
- ||||| zonisamide / Generic mfg.
Enrollment change: A Study to Assess the Efficacy and Safety of Adjunctive Zonisamide in Paediatric Partial Onset Seizures (CATZ Extension Study) (clinicaltrials.gov) - Jan 1, 2013
P3, N=144, Completed, Sponsor: Eisai Limited
Active, not recruiting --> Completed N=204 --> 144
- ||||||| zonisamide / Generic mfg.
Trial completion: A Study to Assess the Efficacy and Safety of Adjunctive Zonisamide in Paediatric Partial Onset Seizures (CATZ Extension Study) (clinicaltrials.gov) - Jan 1, 2013
P3, N=144, Completed, Sponsor: Eisai Limited
N=204 --> 144 Active, not recruiting --> Completed
- ||| zonisamide / Generic mfg.
Enrollment change, Monotherapy: A Study to Evaluate the Safety and Efficacy of Zonisamide an Antiepileptic Drug as Monotherapy or Adjunctive Therapy in Treatment of Adult Patients With Partial, Generalized or Combined Seizures. (clinicaltrials.gov) - Dec 9, 2012
P4, N=655, Completed, Sponsor: Eisai Inc.
Active, not recruiting --> Completed N=900 --> 655
- ||| Empatic (bupropion SR/zonisamide SR) / Currax
Enrollment change, Combination therapy, Monotherapy: Zonisamide SR Plus Bupropion SR Combination Therapy in Subjects With Obesity (clinicaltrials.gov) - Nov 26, 2012
P2b, N=729, Completed, Sponsor: Orexigen Therapeutics, Inc
N=900 --> 655 N=600 --> 729
- ||||||| zonisamide / Generic mfg.
Trial completion: Efficacy and Safety of Adjunctive Zonisamide in Paediatric Partial Onset Seizures (CATZ Study) (clinicaltrials.gov) - Nov 11, 2012
P3, N=207, Completed, Sponsor: Eisai Inc.
N=600 --> 729 Recruiting --> Completed
- | Chantix (varenicline) / Pfizer
New P1/2 trial: Zonisamide Augmentation of Varenicline Treatment for Smoking Cessation (clinicaltrials.gov) - Sep 13, 2012
P1/2, N=200, Active, not recruiting, Sponsor: Johns Hopkins University
- zonisamide / Generic mfg.
Trial initiation date: Adjunctive Zonisamide in Primary Generalised Tonic Clonic Seizures (clinicaltrials.gov) - Sep 10, 2012
P3, N=21, Terminated, Sponsor: Eisai Limited
Recruiting --> Completed Initiation date: May 2008 --> Aug 2008
- | zonisamide / Generic mfg.
Enrollment change: Zonegran for the Treatment of Weight Gain Associated With Psychotropic Medication Use: A Placebo-Controlled Trial (clinicaltrials.gov) - Aug 29, 2012
P4, N=20, Completed, Sponsor: Tuscaloosa Research & Education Advancement Corporation
Initiation date: May 2008 --> Aug 2008 N=60 --> 20
- | zonisamide / Generic mfg.
Trial completion: Zonegran for the Treatment of Weight Gain Associated With Psychotropic Medication Use: A Placebo-Controlled Trial (clinicaltrials.gov) - Aug 29, 2012
P4, N=20, Completed, Sponsor: Tuscaloosa Research & Education Advancement Corporation
N=60 --> 20 Active, not recruiting --> Completed
- zonisamide / Generic mfg.
Enrollment change: Zonisamide for Weight Reduction in Obese Adults (clinicaltrials.gov) - Jul 26, 2012
P=N/A, N=225, Completed, Sponsor: Duke University
Active, not recruiting --> Completed N=300 --> 225
- zonisamide / Generic mfg.
Trial completion: Zonisamide for Weight Reduction in Obese Adults (clinicaltrials.gov) - Jul 26, 2012
P=N/A, N=225, Completed, Sponsor: Duke University
N=300 --> 225 Active, not recruiting --> Completed
- ||||| zonisamide / Generic mfg.
New P4 trial, Head-to-Head: Evaluation of the Efficacy and Safety of Adjunctive Zonisamide vs Replacement With Zonisamide of the Last Added Antiepileptic Drug (clinicaltrials.gov) - Jun 26, 2012
P4, N=200, Recruiting, Sponsor: Eisai Inc.
- zonisamide / Generic mfg.
Enrollment open: Zonisamide for Heavy Drinkers With Bipolar Disorder (clinicaltrials.gov) - May 8, 2012
P2, N=40, Recruiting, Sponsor: VA Connecticut Healthcare System
Active, not recruiting --> Completed Not yet recruiting --> Recruiting
- ||| Potiga (retigabine) / Bausch Health, GSK
Review: Systematic Review: Retigabine for Adjunctive Therapy in Partial Epilepsy (clinicaltrials.gov) - Apr 25, 2012
P=N/A, N=6498, Completed, Sponsor: GlaxoSmithKline
- zonisamide / Generic mfg.
New P2 trial: Zonisamide for Heavy Drinkers With Bipolar Disorder (clinicaltrials.gov) - Mar 27, 2012
P2, N=40, Recruiting, Sponsor: VA Connecticut Healthcare System
- zonisamide / Generic mfg.
New P4 trial: A Study to Evaluate the Safety and Tolerability and Explore the Efficacy of Zonisamide as add-on Therapy in Elderly Patients With Refractory Partial Seizures (clinicaltrials.gov) - Mar 5, 2012
P4, N=41, Terminated, Sponsor: Eisai Limited
- ||||||| zonisamide / Generic mfg.
Trial completion: A Study for Evaluating the Efficacy and Safety of Zonisamide and Lamotrigine (Lamictal) for Subjects With Refractory Simple Partial, Complex Partial or Partial With Secondary Generalized Seizures (clinicaltrials.gov) - Aug 11, 2011
P3, N=64, Completed, Sponsor: Eisai Inc.
Not yet recruiting --> Recruiting Active, not recruiting --> Completed